Participate in our clinical trial

You could be eligible to get no-cost treatment and contribute to research on methamphetamine use disorder

NIH - National Institutes of Health

In partnership with the National Institute on Drug Abuse, Affect Therapeutics is running a clinical trial of its methamphetamine use disorder treatment system in Arizona. The purpose of the trial is to refine the digital treatment and analyze aspects of the program most highly associated with positive participant outcomes, including sustained abstinence from methamphetamine use.

As a participant, you’ll receive eight weeks of treatment, during which you’ll be asked to attend group and individual therapy, self-administered drug screens, and app-based challenges. You’ll also be asked to participate in focus groups and other feedback sessions, both during the eight weeks and at periodic intervals thereafter. The time commitment is roughly four hours a week during the eight weeks, and you’ll have the opportunity to earn up to $350 in incentives for participation in the program. All aspects of the program are conducted digitally over your smartphone.

We are looking for eligible individuals who wish to stop their meth use and who want to participate in our trial. Program services are provided at no cost for research participants.

To meet the basic eligibility requirements, you must:
  • Be 18 years of age or older
  • Be located in Arizona
  • Be able to read and understand English 
  • Be an active meth user with an intent to quit
  • Have a smartphone and be capable of using apps
  • Have a mailing address
  • Have medical insurance (to cover medication, if recommended)
  • Not be experiencing any serious medical conditions
  • Not suffer from a severe co-occurring opiate addiction
  • Not currently be enrolled in any other addiction treatment program (inpatient or outpatient)

Please complete this short survey to affirm your eligibility to participate. One of our research associates will reach out to you immediately.

As Seen On

Affect's innovative approach to treating the meth and crack crisis and beating addiction has been recognized by Forbes magazine
Tech Crunch covered how Affect is treating meth and cocaine addiction with an innovative digital recovery program backed by science and data
Cheddar News covered Affect's use of gamification and game design theory to activate the brain's reward center and get meth and cocaine addicts hooked on their recovery